Portfolio Holdings Detail for ISIN IE00BYZK4776
Stock Name / Fund iShares Healthcare Innovation UCITS ETF USD (Acc)
Issuer Blackrock
Entity holding fund iShares IV Public Limited Company
Entity Type Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300ZP07LMR36K1T02
ETF Ticker DRDR(GBX) LSE
ETF Ticker 2B78(EUR) F
ETF Ticker 2B78.DE(EUR) CXE
ETF Ticker DRDR.LS(GBX) CXE
ETF Ticker HEAL.AS(EUR) CXE
ETF Ticker HEAL.LS(USD) CXE
ETF Ticker HEALz(USD) CXE
ETF Ticker HEAL(EUR) ETF Plus
ETF Ticker DRDR.L(GBP) LSE

Holdings detail for VNDA

Stock Name	Vanda Pharmaceuticals Inc
Ticker	VNDA(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	US9216591084
LEI	529900AY8VOOQBKJ0O70

Show aggregate VNDA holdings

News associated with VNDA

XTX Topco Ltd Has $318,000 Holdings in Vanda Pharmaceuticals Inc. (NASDAQ:VNDA): XTX Topco Ltd grew its holdings in shares of Vanda Pharmaceuticals Inc. (NASDAQ:VNDA – Free Report) by 378.3% during the first quarter, HoldingsChannel.com reports. The firm owned 69,329 shares of the biopharmaceutical company’s stock after acquiring an additional 54,833 shares during the quarter. XTX Topco Ltd’s holdings in Vanda Pharmaceuticals were worth $318,000 as of […] - 2025-08-11 05:34:58
Vanda (VNDA) Q2 Revenue Rises 4%: Key PointsNet loss (GAAP) widened sharply due to increased spending in Q2 2025, with GAAP EPS was ($0.46) for Q2 2025. - 2025-08-01 05:18:57
GSA Capital Partners LLP Raises Position in Vanda Pharmaceuticals Inc. (NASDAQ:VNDA): GSA Capital Partners LLP increased its stake in Vanda Pharmaceuticals Inc. (NASDAQ:VNDA – Free Report) by 88.0% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 260,215 shares of the biopharmaceutical company’s stock after acquiring an additional 121,797 shares during the […] - 2025-07-31 04:29:06
Public Employees Retirement System of Ohio Has $426,000 Stock Position in Vanda Pharmaceuticals Inc. (NASDAQ:VNDA): Public Employees Retirement System of Ohio reduced its position in Vanda Pharmaceuticals Inc. (NASDAQ:VNDA – Free Report) by 16.2% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 89,032 shares of the biopharmaceutical company’s stock after selling 17,200 shares during the period. Public Employees Retirement System of Ohio […] - 2025-06-05 05:23:00
Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Shares Acquired by Two Sigma Advisers LP: Two Sigma Advisers LP raised its stake in shares of Vanda Pharmaceuticals Inc. (NASDAQ:VNDA – Free Report) by 11.2% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 156,300 shares of the biopharmaceutical company’s stock after acquiring an additional 15,700 shares […] - 2025-06-03 04:56:54
Short Interest in Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Expands By 21.4%: Vanda Pharmaceuticals Inc. (NASDAQ:VNDA – Get Free Report) saw a significant increase in short interest in April. As of April 15th, there was short interest totalling 4,880,000 shares, an increase of 21.4% from the March 31st total of 4,020,000 shares. Based on an average daily volume of 663,100 shares, the days-to-cover ratio is currently 7.4 […] - 2025-05-05 02:35:06
XTX Topco Ltd Makes New Investment in Vanda Pharmaceuticals Inc. (NASDAQ:VNDA): XTX Topco Ltd purchased a new position in Vanda Pharmaceuticals Inc. (NASDAQ:VNDA – Free Report) in the 4th quarter, Holdings Channel reports. The institutional investor purchased 14,496 shares of the biopharmaceutical company’s stock, valued at approximately $69,000. A number of other hedge funds also recently modified their holdings of VNDA. Geode Capital Management LLC boosted […] - 2025-05-01 05:28:58
Geode Capital Management LLC Buys 24,483 Shares of Vanda Pharmaceuticals Inc. (NASDAQ:VNDA): Geode Capital Management LLC raised its position in shares of Vanda Pharmaceuticals Inc. (NASDAQ:VNDA – Free Report) by 1.7% in the fourth quarter, HoldingsChannel reports. The fund owned 1,450,310 shares of the biopharmaceutical company’s stock after acquiring an additional 24,483 shares during the period. Geode Capital Management LLC’s holdings in Vanda Pharmaceuticals were worth $6,949,000 […] - 2025-04-25 04:26:50
Vanguard Group Inc. Has $16.80 Million Position in Vanda Pharmaceuticals Inc. (NASDAQ:VNDA): Vanguard Group Inc. lessened its holdings in Vanda Pharmaceuticals Inc. (NASDAQ:VNDA – Free Report) by 3.4% during the 4th quarter, HoldingsChannel reports. The institutional investor owned 3,506,287 shares of the biopharmaceutical company’s stock after selling 125,002 shares during the period. Vanguard Group Inc. owned approximately 0.06% of Vanda Pharmaceuticals worth $16,795,000 as of its most […] - 2025-04-17 04:25:09
ExodusPoint Capital Management LP Decreases Stake in Vanda Pharmaceuticals Inc. (NASDAQ:VNDA): ExodusPoint Capital Management LP trimmed its holdings in shares of Vanda Pharmaceuticals Inc. (NASDAQ:VNDA – Free Report) by 74.9% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 31,506 shares of the biopharmaceutical company’s stock after selling 94,144 shares during the quarter. ExodusPoint […] - 2025-04-15 04:39:18
American Century Companies Inc. Raises Stock Holdings in Vanda Pharmaceuticals Inc. (NASDAQ:VNDA): American Century Companies Inc. increased its holdings in shares of Vanda Pharmaceuticals Inc. (NASDAQ:VNDA – Free Report) by 2.1% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 300,276 shares of the biopharmaceutical company’s stock after acquiring an additional 6,079 shares during the […] - 2025-04-10 04:28:52
135,400 Shares in Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Bought by KLP Kapitalforvaltning AS: KLP Kapitalforvaltning AS bought a new stake in Vanda Pharmaceuticals Inc. (NASDAQ:VNDA – Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 135,400 shares of the biopharmaceutical company’s stock, valued at approximately $649,000. KLP Kapitalforvaltning AS owned […] - 2025-04-02 05:16:59
Bank of New York Mellon Corp Cuts Holdings in Vanda Pharmaceuticals Inc. (NASDAQ:VNDA): Bank of New York Mellon Corp lessened its stake in Vanda Pharmaceuticals Inc. (NASDAQ:VNDA – Free Report) by 14.7% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 175,017 shares of the biopharmaceutical company’s stock after selling 30,260 shares during the quarter. Bank of New York Mellon Corp’s […] - 2025-03-26 05:12:48
Reviewing Vanda Pharmaceuticals (NASDAQ:VNDA) & Rapport Therapeutics (NASDAQ:RAPP): Vanda Pharmaceuticals (NASDAQ:VNDA – Get Free Report) and Rapport Therapeutics (NASDAQ:RAPP – Get Free Report) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their dividends, valuation, institutional ownership, earnings, profitability, risk and analyst recommendations. Analyst Ratings This is a breakdown of […] - 2025-03-25 03:36:46
Vanda Pharmaceuticals (NASDAQ:VNDA) Given New $20.00 Price Target at HC Wainwright: Vanda Pharmaceuticals (NASDAQ:VNDA – Free Report) had its price target upped by HC Wainwright from $18.00 to $20.00 in a research note issued to investors on Tuesday morning,Benzinga reports. HC Wainwright currently has a buy rating on the biopharmaceutical company’s stock. Separately, StockNews.com initiated coverage on Vanda Pharmaceuticals in a report on Wednesday, February 5th. […] - 2025-02-19 04:56:52
Vanda Pharmaceuticals (NASDAQ:VNDA) Now Covered by StockNews.com: Analysts at StockNews.com began coverage on shares of Vanda Pharmaceuticals (NASDAQ:VNDA – Get Free Report) in a research report issued on Wednesday. The brokerage set a “hold” rating on the biopharmaceutical company’s stock. Separately, HC Wainwright reiterated a “buy” rating and issued a $18.00 price objective on shares of Vanda Pharmaceuticals in a research report […] - 2025-02-07 04:20:53
Comparing Vanda Pharmaceuticals (NASDAQ:VNDA) & Cyclerion Therapeutics (NASDAQ:CYCN): Vanda Pharmaceuticals (NASDAQ:VNDA – Get Free Report) and Cyclerion Therapeutics (NASDAQ:CYCN – Get Free Report) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their valuation, earnings, profitability, analyst recommendations, risk, institutional ownership and dividends. Profitability This table compares Vanda Pharmaceuticals and […] - 2025-02-05 04:26:43

iShares Healthcare Innovation UCITS ETF USD (Acc) VNDA holdings

Date	Number of VNDA Shares Held	Base Market Value of VNDA Shares	Local Market Value of VNDA Shares	Change in VNDA Base Value	Current Price per VNDA Share Held	Previous Price per VNDA Share Held
2025-11-11 (Tuesday)	69,114	USD 302,719	USD 302,719	USD -2,765	USD 4.38	USD 4.42
2025-11-10 (Monday)	69,114	USD 305,484	USD 305,484	USD 1,382	USD 4.42	USD 4.40001
2025-11-07 (Friday)	69,114	USD 304,102	USD 304,102	USD -691	USD 4.40001	USD 4.41
2025-11-06 (Thursday)	69,114	USD 304,793	USD 304,793	USD -2,073	USD 4.41	USD 4.44
2025-11-05 (Wednesday)	69,114	USD 306,866	USD 306,866	USD 6,220	USD 4.44	USD 4.35
2025-11-04 (Tuesday)	69,114	USD 300,646	USD 300,646	USD -8,294	USD 4.35	USD 4.47001
2025-11-03 (Monday)	69,114	USD 308,940	USD 308,940	USD 8,294	USD 4.47001	USD 4.35
2025-10-31 (Friday)	69,114	USD 300,646	USD 300,646	USD 2,074	USD 4.35	USD 4.31999
2025-10-30 (Thursday)	69,114	USD 298,572	USD 298,572	USD -75,335	USD 4.31999	USD 5.41
2025-10-29 (Wednesday)	69,114	USD 373,907	USD 373,907	USD -11,749	USD 5.41	USD 5.58
2025-10-28 (Tuesday)	69,114	USD 385,656	USD 385,656	USD -2,074	USD 5.58	USD 5.61001
2025-10-27 (Monday)	69,114	USD 387,730	USD 387,730	USD 7,603	USD 5.61001	USD 5.5

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of VNDA by Blackrock for IE00BYZK4776

Show aggregate share trades of VNDA

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-10-24 SELL -602 5.500 5.620 5.608 USD -3,376 4.67 Loss of -565 on sale
2025-09-11 BUY 309 4.600 4.600 4.600 USD 1,421 4.62
2025-07-08 SELL -300 4.860 4.980 4.968 USD -1,490 4.61 Loss of -108 on sale
2025-06-24 SELL -315 4.500 4.510 4.509 USD -1,420 4.60 Profit of 27 on sale
2025-06-23 SELL -315 4.470 4.550 4.542 USD -1,431 4.60 Profit of 17 on sale
2025-06-11 SELL -308 4.580 4.720 4.706 USD -1,449 4.60 Loss of -33 on sale
2025-05-30 SELL -309 4.340 4.410 4.403 USD -1,361 4.61 Profit of 63 on sale
2025-05-21 BUY 309 4.320 4.470 4.455 USD 1,377 4.63
2025-05-14 SELL -1,836 3.920 3.980 3.974 USD -7,296 4.64 Profit of 1,228 on sale
2025-04-30 SELL -304 4.510 4.540 4.537 USD -1,379 4.68 Profit of 42 on sale
2025-04-28 SELL -304 4.300 4.320 4.318 USD -1,313 4.68 Profit of 111 on sale
2025-04-25 SELL -304 4.250 4.280 4.277 USD -1,300 4.69 Profit of 125 on sale
2025-04-11 SELL -1,932 4.130 4.160 4.157 USD -8,031 4.72 Profit of 1,086 on sale
2025-04-08 SELL -939 4.140 4.300 4.284 USD -4,023 4.74 Profit of 428 on sale
2025-04-07 SELL -648 4.190 4.260 4.253 USD -2,756 4.75 Profit of 320 on sale
2025-03-31 SELL -624 4.590 4.730 4.716 USD -2,943 4.76 Profit of 28 on sale
2025-03-21 SELL -612 4.770 4.960 4.941 USD -3,024 4.76 Loss of -109 on sale
2025-03-12 SELL -322 4.950 5.100 5.085 USD -1,637 4.74 Loss of -110 on sale
2025-02-28 SELL -323 4.760 4.790 4.787 USD -1,546 4.73 Loss of -19 on sale
2025-02-25 BUY 324 4.460 4.500 4.496 USD 1,457 4.73
2025-02-20 SELL -324 4.490 4.650 4.634 USD -1,501 4.75 Profit of 37 on sale
2025-02-19 BUY 648 4.550 4.640 4.631 USD 3,001 4.75
2025-02-18 BUY 324 4.460 4.600 4.586 USD 1,486 4.76
2024-12-30 SELL -618 4.780 4.900 4.888 USD -3,021 4.88 Loss of -7 on sale
2024-12-06 SELL -296 4.840 4.870 4.867 USD -1,441 4.89 Profit of 6 on sale
2024-12-04 SELL -297 4.840 4.910 4.903 USD -1,456 4.89 Loss of -3 on sale
2024-12-03 SELL -598 4.910 5.040 5.027 USD -3,006 4.89 Loss of -80 on sale
2024-11-21 SELL -317 4.940 4.940 4.940 USD -1,566 4.82 Loss of -39 on sale
2024-11-20 SELL -324 4.900 4.920 4.918 USD -1,593 4.81 Loss of -35 on sale
2024-11-19 SELL -325 4.920 4.960 4.956 USD -1,611 4.80 Loss of -49 on sale
2024-11-18 SELL -1,224 4.980 5.070 5.061 USD -6,195 4.79 Loss of -327 on sale
2024-11-12 SELL -305 5.400 5.550 5.535 USD -1,688 4.75 Loss of -238 on sale
2024-11-07 SELL -304 5.020 5.300 5.272 USD -1,603 4.70 Loss of -174 on sale
2024-11-05 SELL -610 4.790 4.800 4.799 USD -2,927 4.67 Loss of -76 on sale
2024-10-28 SELL -307 4.780 4.790 4.789 USD -1,470 4.64 Loss of -45 on sale
Market high and low price is on the date.

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-10-24	SELL	-602	5.500	5.620	5.608	USD -3,376	4.67 Loss of -565 on sale
2025-09-11	BUY	309	4.600	4.600	4.600	USD 1,421	4.62
2025-07-08	SELL	-300	4.860	4.980	4.968	USD -1,490	4.61 Loss of -108 on sale
2025-06-24	SELL	-315	4.500	4.510	4.509	USD -1,420	4.60 Profit of 27 on sale
2025-06-23	SELL	-315	4.470	4.550	4.542	USD -1,431	4.60 Profit of 17 on sale
2025-06-11	SELL	-308	4.580	4.720	4.706	USD -1,449	4.60 Loss of -33 on sale
2025-05-30	SELL	-309	4.340	4.410	4.403	USD -1,361	4.61 Profit of 63 on sale
2025-05-21	BUY	309	4.320	4.470	4.455	USD 1,377	4.63
2025-05-14	SELL	-1,836	3.920	3.980	3.974	USD -7,296	4.64 Profit of 1,228 on sale
2025-04-30	SELL	-304	4.510	4.540	4.537	USD -1,379	4.68 Profit of 42 on sale
2025-04-28	SELL	-304	4.300	4.320	4.318	USD -1,313	4.68 Profit of 111 on sale
2025-04-25	SELL	-304	4.250	4.280	4.277	USD -1,300	4.69 Profit of 125 on sale
2025-04-11	SELL	-1,932	4.130	4.160	4.157	USD -8,031	4.72 Profit of 1,086 on sale
2025-04-08	SELL	-939	4.140	4.300	4.284	USD -4,023	4.74 Profit of 428 on sale
2025-04-07	SELL	-648	4.190	4.260	4.253	USD -2,756	4.75 Profit of 320 on sale
2025-03-31	SELL	-624	4.590	4.730	4.716	USD -2,943	4.76 Profit of 28 on sale
2025-03-21	SELL	-612	4.770	4.960	4.941	USD -3,024	4.76 Loss of -109 on sale
2025-03-12	SELL	-322	4.950	5.100	5.085	USD -1,637	4.74 Loss of -110 on sale
2025-02-28	SELL	-323	4.760	4.790	4.787	USD -1,546	4.73 Loss of -19 on sale
2025-02-25	BUY	324	4.460	4.500	4.496	USD 1,457	4.73
2025-02-20	SELL	-324	4.490	4.650	4.634	USD -1,501	4.75 Profit of 37 on sale
2025-02-19	BUY	648	4.550	4.640	4.631	USD 3,001	4.75
2025-02-18	BUY	324	4.460	4.600	4.586	USD 1,486	4.76
2024-12-30	SELL	-618	4.780	4.900	4.888	USD -3,021	4.88 Loss of -7 on sale
2024-12-06	SELL	-296	4.840	4.870	4.867	USD -1,441	4.89 Profit of 6 on sale
2024-12-04	SELL	-297	4.840	4.910	4.903	USD -1,456	4.89 Loss of -3 on sale
2024-12-03	SELL	-598	4.910	5.040	5.027	USD -3,006	4.89 Loss of -80 on sale
2024-11-21	SELL	-317	4.940	4.940	4.940	USD -1,566	4.82 Loss of -39 on sale
2024-11-20	SELL	-324	4.900	4.920	4.918	USD -1,593	4.81 Loss of -35 on sale
2024-11-19	SELL	-325	4.920	4.960	4.956	USD -1,611	4.80 Loss of -49 on sale
2024-11-18	SELL	-1,224	4.980	5.070	5.061	USD -6,195	4.79 Loss of -327 on sale
2024-11-12	SELL	-305	5.400	5.550	5.535	USD -1,688	4.75 Loss of -238 on sale
2024-11-07	SELL	-304	5.020	5.300	5.272	USD -1,603	4.70 Loss of -174 on sale
2024-11-05	SELL	-610	4.790	4.800	4.799	USD -2,927	4.67 Loss of -76 on sale
2024-10-28	SELL	-307	4.780	4.790	4.789	USD -1,470	4.64 Loss of -45 on sale

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of VNDA

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	42,774	2,453	131,244	32.6%
2025-09-18	25,487	0	103,697	24.6%
2025-09-17	42,313	0	99,513	42.5%
2025-09-16	16,592	0	110,453	15.0%
2025-09-15	49,998	4,027	122,733	40.7%
2025-09-12	55,842	0	160,488	34.8%
2025-09-11	42,447	0	110,256	38.5%
2025-09-10	25,113	1,000	115,790	21.7%
2025-09-09	31,129	446	70,773	44.0%
2025-09-08	28,194	0	68,400	41.2%
2025-09-05	27,068	0	125,697	21.5%
2025-09-04	113,956	17,115	231,507	49.2%
2025-09-03	54,340	0	112,436	48.3%
2025-09-02	52,592	4,793	241,174	21.8%
2025-08-29	26,190	0	81,421	32.2%
2025-08-28	45,898	0	150,189	30.6%
2025-08-27	19,368	5,600	96,935	20.0%
2025-08-26	52,199	200	124,704	41.9%
2025-08-25	40,000	199	161,310	24.8%
2025-08-22	45,003	0	127,801	35.2%
2025-08-21	57,678	0	170,952	33.7%
2025-08-20	22,347	0	105,692	21.1%
2025-08-19	55,399	203	176,148	31.5%
2025-08-18	188,374	11,471	480,631	39.2%
2025-08-15	47,358	0	111,575	42.4%
2025-08-14	56,845	7	138,850	40.9%
2025-08-13	47,990	0	178,443	26.9%
2025-08-12	83,180	8,700	251,642	33.1%
2025-08-11	58,803	0	148,163	39.7%
2025-08-08	57,309	0	117,859	48.6%
2025-08-07	87,919	2,763	143,066	61.5%
2025-08-06	139,442	3,417	252,623	55.2%
2025-08-05	71,928	0	173,007	41.6%
2025-08-04	102,812	118	269,247	38.2%
2025-08-01	168,331	9,932	356,470	47.2%
2025-07-31	366,630	25,169	758,404	48.3%
2025-07-30	101,622	19,723	407,514	24.9%
2025-07-29	54,833	0	160,273	34.2%
2025-07-28	35,669	8,395	106,256	33.6%
2025-07-25	90,519	4	154,637	58.5%
2025-07-24	49,307	648	146,927	33.6%
2025-07-23	69,319	0	165,089	42.0%
2025-07-22	42,768	8,190	106,058	40.3%
2025-07-21	51,559	500	211,909	24.3%
2025-07-18	52,510	10	131,904	39.8%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.

Stock Name / Fund	iShares Healthcare Innovation UCITS ETF USD (Acc)
Issuer	Blackrock
Entity holding fund	iShares IV Public Limited Company
Entity Type	Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI	549300ZP07LMR36K1T02
ETF Ticker	DRDR(GBX) LSE
ETF Ticker	2B78(EUR) F
ETF Ticker	2B78.DE(EUR) CXE
ETF Ticker	DRDR.LS(GBX) CXE
ETF Ticker	HEAL.AS(EUR) CXE
ETF Ticker	HEAL.LS(USD) CXE
ETF Ticker	HEALz(USD) CXE
ETF Ticker	HEAL(EUR) ETF Plus
ETF Ticker	DRDR.L(GBP) LSE